By using bispecific antibodies targeting a tumor-associated antigen (TAA) on the cancer cells, and CD3 on the T-cells, it is possible to redirect and activate any circulating T-cells against tumor cells independently of the specificity of their TCR. Thanks to the bridging action of such TAAxCD3 bsAb, T-cells are brought in close proximity of the target cancer cells, leading to subsequent T-cell activation and T-cell–mediated killing of the tumor cells.
For more information on T-cell redirecting κλ-bodies, please visit Light Chain Bioscience.
Read our latest news
We are delighted to announce SIX exciting new articles featuring Nanolive’s 3D Cell Explorer. The articles come from users based in Taiwan, Poland, Spain, and Belgium, respectively. TP3, an antimicrobial peptide, inhibits infiltration and motility of glioblastoma...
We are delighted to announce three very exciting new PARISITOLOGY articles featuring Nanolive’s 3D Cell Explorer – ALL of which have been published this year by our prolific clients at the Justus Liebig University (Giessen, Germany) and their co-authors in Colombia...
We are happy to announce our next webinar with the topic "Accelerating oncology drug discovery with label-free imaging" on July 7th and 8th. In this webinar, Dr. Emma Gibbin, Communications Specialist at Nanolive will discuss the advantages of using label-free live...
3D CELL EXPLORER
Budget-friendly, easy-to-use, compact solution for high quality non-invasive 4D live cell imaging
3D CELL EXPLORER-fluo
Multimodal Complete Solution: combine high quality non-invasive 4D live cell imaging with fluorescence